Please note that the content has been automatically translated from English original. There may on occasion be slight inaccuracies in this automatic translation

News

IDDO infographic

IDDO’s latest newsletter is out

IDDO at the Geneva Health Forum 4 May 2022

ANTICOV trial finds drug combination nitazoxanide + ciclesonide does not reduce risk of hospitalization in COVID-19 outpatients

School girls

Credit Jessica Lea, DFID

Applications open for RSTMH 2022 grant programme

ANTICOV: clinical trial for COVID-19 in low-resource settings to test a new combination treatment, fluoxetine and budesonide

covid19

IDDO to make its COVID-19 studies discoverable on the Vivli platform

Global map

IDDO to share latest research at ECTMIH 2021

Blurred people on a busy street

CREDIT: Mauro Mora

Preprints: it’s time to agree on terminology and best practice

ANTICOV: largest clinical trial in Africa for people with mild COVID-19 to test new drug combination

Professor Philippe Guérin

Calls for clarity on pooled evidence in COVID-19 therapeutic reviews and guidelines

Gloved hand holding syringe inserted into small vial

Credit: Stockphotokun

New report highlights growing concern of vaccine falsification

Children eating

Photo credit: Erly Tatontos, World Bank

Applications for RSTMH 2021 grants open